| Year |
Citation |
Score |
| 2022 |
Heslop KA, Burger P, Kappler C, Solanki AK, Gooz M, Peterson YK, Mills C, Benton T, Duncan SA, Woster PM, Maldonado EN. Small molecules targeting the NADH-binding pocket of VDAC modulate mitochondrial metabolism in hepatocarcinoma cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 150: 112928. PMID 35447542 DOI: 10.1016/j.biopha.2022.112928 |
0.392 |
|
| 2022 |
Turner J, Muraoka A, Bedenbaugh M, Childress B, Pernot L, Wiencek M, Peterson YK. The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition. Frontiers in Microbiology. 13: 807955. PMID 35401470 DOI: 10.3389/fmicb.2022.807955 |
0.274 |
|
| 2022 |
Motamarry A, Wolfe AM, Ramajayam KK, Pattanaik S, Benton T, Peterson Y, Faridi P, Prakash P, Twombley K, Haemmerich D. Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities. Cancers. 14. PMID 35267630 DOI: 10.3390/cancers14051322 |
0.242 |
|
| 2021 |
Benton TZ, Mills CM, Turner JM, Francis MJ, Solomon DJ, Burger PB, Peterson YK, Dolloff NG, Bachmann AS, Woster PM. Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation. Rsc Advances. 11: 33260-33270. PMID 35497564 DOI: 10.1039/d1ra06266b |
0.286 |
|
| 2021 |
Sullivan LS, Pelzer D, Rice A, Peterson YK, Sade RM, Townsend DM, Vaughan L, Nichols M, Zisk N. Responsibility for Structural Racism in Medicine: Reflections and Recommendations from One Institution. Narrative Inquiry in Bioethics. 11: 221-229. PMID 34840187 DOI: 10.1353/nib.2021.0073 |
0.201 |
|
| 2021 |
Beeson C, Peterson YK, Perron N, Bandyopadhyay M, Nasarre C, Beeson G, Comer RF, Lindsey CC, Schnellmann RG, Rohrer B. Newly Identified Chemicals Preserve Mitochondrial Capacity and Decelerate Loss of Photoreceptor Cells in Murine Retinal Degeneration Models. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. PMID 33945330 DOI: 10.1089/jop.2020.0140 |
0.529 |
|
| 2020 |
Dimou A, Nasarre C, Peterson YK, Pagano R, Gooz M, Nasarre P, Drabkin HA, Armeson KE, Gibney BC, Gemmill RM, Denlinger CE. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. PMID 32653291 DOI: 10.1016/J.Jtcvs.2020.03.166 |
0.25 |
|
| 2020 |
Li X, Jiang Y, Peterson YK, Tongqiang X, Himes RA, Xin L, Yin G, Inks ES, Dolloff N, Halene S, Chan SSL, Chou CJ. Design of hydrazide-bearing HDACIs based on panobinostat and their p53 and FLT3-ITD dependency in anti-leukemia activity. Journal of Medicinal Chemistry. PMID 32321249 DOI: 10.1021/acs.jmedchem.0c00442 |
0.293 |
|
| 2019 |
Garcia D, Nasarre P, Bonilla IV, Hilliard E, Peterson YK, Spruill L, Broome AM, Hill EG, Yustein JT, Mehrotra S, Klauber-DeMore N. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Annals of Surgical Oncology. PMID 31515721 DOI: 10.1245/S10434-019-07800-2 |
0.264 |
|
| 2019 |
Holshouser S, Dunworth M, Murray-Stewart T, Peterson YK, Burger P, Kirkpatrick J, Chen HH, Casero RA, Woster PM. Dual inhibitors of LSD1 and spermine oxidase. Medchemcomm. 10: 778-790. PMID 31191868 DOI: 10.1039/C8Md00610E |
0.296 |
|
| 2019 |
Cameron RB, Peterson YK, Beeson CC, Schnellmann RG. Author Correction: Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol. Scientific Reports. 9: 6790. PMID 31043635 DOI: 10.1038/S41598-019-42463-9 |
0.492 |
|
| 2019 |
De Palma RM, Parnham SR, Li Y, Oaks JJ, Peterson YK, Szulc ZM, Roth BM, Xing Y, Ogretmen B. The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802264R. PMID 30917007 DOI: 10.1096/Fj.201802264R |
0.309 |
|
| 2019 |
Dimou A, Nasarre C, Gooz M, Pagano R, Peterson Y, Armeson K, Drabkin HA, Nasarre P, Denlinger CE, Gemmill RM. Abstract 2624: NRP2b promotes migration, drug resistance and AKT activation in lung cancers by recruiting GSK3â to phosphorylate and destabilize PTEN Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2624 |
0.346 |
|
| 2018 |
Nganga R, Oleinik N, Kim J, Panneer Selvam S, De Palma R, Johnson KA, Parikh RY, Gangaraju V, Peterson Y, Dany M, Stahelin RV, Voelkel-Johnson C, Szulc ZM, Bieberich E, Ogretmen B. Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis. The Journal of Biological Chemistry. PMID 30420430 DOI: 10.1074/Jbc.Ra118.005865 |
0.398 |
|
| 2018 |
Crona DJ, Skol AD, Leppänen VM, Glubb DM, Etheridge AS, Hilliard E, Peña CE, Peterson YK, Klauber-DeMore N, Alitalo KK, Innocenti F. Genetic variants of VEGFA and FLT4 are determinants of survival in renal cell carcinoma patients treated with sorafenib. Cancer Research. PMID 30385613 DOI: 10.1158/0008-5472.Can-18-1089 |
0.234 |
|
| 2018 |
Li X, Peterson YK, Inks ES, Himes R, Li J, Zhang Y, Kong X, Chou CJ. Class I HDAC inhibitors display different anti-tumor mechanism in leukemia and prostatic cancer cells depended on their p53 status. Journal of Medicinal Chemistry. PMID 29499113 DOI: 10.1021/acs.jmedchem.8b00136 |
0.339 |
|
| 2018 |
Strungs E, Appleton K, Kwon J, Robinson K, Peterson Y, Luttrell L, Lee M. Application of Intramolecular FlAsH-BRET to the Classification Arrestin Activation Modes Protocol Exchange. DOI: 10.1038/Protex.2017.149 |
0.634 |
|
| 2017 |
Qie S, Majumder M, Mackiewicz K, Howley BV, Peterson YK, Howe PH, Palanisamy V, Diehl JA. Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Nature Communications. 8: 1534. PMID 29142209 DOI: 10.1038/s41467-017-01199-8 |
0.31 |
|
| 2017 |
Peterson YK, Nasarre P, Bonilla IV, Hilliard E, Samples J, Morinelli TA, Hill EG, Klauber-DeMore N. Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis. Angiogenesis. PMID 28840375 DOI: 10.1007/S10456-017-9574-5 |
0.385 |
|
| 2017 |
Peterson YK, Luttrell LM. The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling. Pharmacological Reviews. 69: 256-297. PMID 28626043 DOI: 10.1124/pr.116.013367 |
0.404 |
|
| 2017 |
McClure JJ, Inks ES, Zhang C, Peterson YK, Li J, Choudhary K, Lee B, Buchanan A, Miao S, Chou CJ. Comparison of the deacylase and deacetylase activity of zinc-dependent HDACs. Acs Chemical Biology. PMID 28459537 DOI: 10.1021/acschembio.7b00321 |
0.298 |
|
| 2016 |
McClure J, Zhang C, Inks E, Peterson YK, Li J, Chou CJ. Development of Allosteric Hydrazide-Containing Class I Histone Deacetylase Inhibitors for Use in Acute Myeloid Leukemia. Journal of Medicinal Chemistry. PMID 27754681 DOI: 10.1021/acs.jmedchem.6b01385 |
0.319 |
|
| 2016 |
Trager RE, Giblock P, Soltani S, Upadhyay AA, Rekapalli B, Peterson YK. Docking optimization, variance and promiscuity for large-scale drug-like chemical space using high performance computing architectures. Drug Discovery Today. PMID 27352630 DOI: 10.1016/J.Drudis.2016.06.023 |
0.738 |
|
| 2016 |
Lee MH, Appleton KM, Strungs EG, Kwon JY, Morinelli TA, Peterson YK, Laporte SA, Luttrell LM. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions. Nature. PMID 27007854 DOI: 10.1038/Nature17154 |
0.688 |
|
| 2015 |
Panneer Selvam S, De Palma RM, Oaks JJ, Oleinik N, Peterson YK, Stahelin RV, Skordalakes E, Ponnusamy S, Garrett-Mayer E, Smith CD, Ogretmen B. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. Science Signaling. 8: ra58. PMID 26082434 DOI: 10.1126/Scisignal.Aaa4998 |
0.306 |
|
| 2015 |
Leonard AP, Cameron RB, Speiser JL, Wolf BJ, Peterson YK, Schnellmann RG, Beeson CC, Rohrer B. Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning. Biochimica Et Biophysica Acta. 1853: 348-60. PMID 25447550 DOI: 10.1016/J.Bbamcr.2014.11.002 |
0.537 |
|
| 2014 |
Prakasam A, Ghose S, Oleinik NV, Bethard JR, Peterson YK, Krupenko NI, Krupenko SA. JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1. Cell Death & Disease. 5: e1358. PMID 25077544 DOI: 10.1038/cddis.2014.316 |
0.311 |
|
| 2014 |
Appleton KM, Bigham KJ, Lindsey CC, Hazard S, Lirjoni J, Parnham S, Hennig M, Peterson YK. Development of inhibitors of heterotrimeric Gαi subunits. Bioorganic & Medicinal Chemistry. 22: 3423-34. PMID 24818958 DOI: 10.1016/J.Bmc.2014.04.035 |
0.718 |
|
| 2014 |
Raymond JR, Appleton KM, Pierce JY, Peterson YK. Suppression of GNAI2 message in ovarian cancer. Journal of Ovarian Research. 7: 6. PMID 24423449 DOI: 10.1186/1757-2215-7-6 |
0.669 |
|
| 2013 |
Peterson YK, Cameron RB, Wills LP, Trager RE, Lindsey CC, Beeson CC, Schnellmann RG. β2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis. Bioorganic & Medicinal Chemistry Letters. 23: 5376-81. PMID 23954364 DOI: 10.1016/J.Bmcl.2013.07.052 |
0.765 |
|
| 2013 |
Wills LP, Beeson GC, Trager RE, Lindsey CC, Beeson CC, Peterson YK, Schnellmann RG. High-throughput respirometric assay identifies predictive toxicophore of mitochondrial injury. Toxicology and Applied Pharmacology. 272: 490-502. PMID 23811330 DOI: 10.1016/J.Taap.2013.06.014 |
0.741 |
|
| 2013 |
Wilson PC, Lee MH, Appleton KM, El-Shewy HM, Morinelli TA, Peterson YK, Luttrell LM, Jaffa AA. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. The Journal of Biological Chemistry. 288: 18872-84. PMID 23661707 DOI: 10.1074/Jbc.M113.472381 |
0.646 |
|
| 2013 |
Appleton KM, Lee MH, Alele C, Alele C, Luttrell DK, Peterson YK, Morinelli TA, Luttrell LM. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity. Methods in Enzymology. 522: 229-62. PMID 23374189 DOI: 10.1016/B978-0-12-407865-9.00013-3 |
0.682 |
|
| 2013 |
Leonard AP, Appleton KM, Luttrell LM, Peterson YK. A high-content, live-cell, and real-time approach to the quantitation of ligand-induced β-Arrestin2 and Class A/Class B GPCR mobilization. Microscopy and Microanalysis : the Official Journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 19: 150-70. PMID 23351552 DOI: 10.1017/S1431927612014067 |
0.657 |
|
| 2013 |
Saddoughi SA, Gencer S, Peterson YK, Ward KE, Mukhopadhyay A, Oaks J, Bielawski J, Szulc ZM, Thomas RJ, Selvam SP, Senkal CE, Garrett-Mayer E, De Palma RM, Fedarovich D, Liu A, et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. Embo Molecular Medicine. 5: 105-21. PMID 23180565 DOI: 10.1002/Emmm.201201283 |
0.3 |
|
| 2012 |
Fedarovich A, Djordjevic KA, Swanson SM, Peterson YK, Nicholas RA, Davies C. High-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2. Plos One. 7: e44918. PMID 23049763 DOI: 10.1371/Journal.Pone.0044918 |
0.352 |
|
| 2012 |
Gao P, Peterson YK, Smith RA, Smith CD. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases. Plos One. 7: e44543. PMID 22970244 DOI: 10.1371/journal.pone.0044543 |
0.352 |
|
| 2012 |
Sentelle RD, Senkal CE, Jiang W, Ponnusamy S, Gencer S, Selvam SP, Ramshesh VK, Peterson YK, Lemasters JJ, Szulc ZM, Bielawski J, Ogretmen B. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nature Chemical Biology. 8: 831-8. PMID 22922758 DOI: 10.1038/Nchembio.1059 |
0.353 |
|
| 2012 |
Perera MN, Lin SH, Peterson YK, Bielawska A, Szulc ZM, Bittman R, Colombini M. Bax and Bcl-xL exert their regulation on different sites of the ceramide channel. The Biochemical Journal. 445: 81-91. PMID 22494048 DOI: 10.1042/Bj20112103 |
0.3 |
|
| 2012 |
Wills LP, Trager RE, Beeson GC, Lindsey CC, Peterson YK, Beeson CC, Schnellmann RG. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. The Journal of Pharmacology and Experimental Therapeutics. 342: 106-18. PMID 22490378 DOI: 10.1124/Jpet.112.191528 |
0.753 |
|
| 2012 |
Rhoades JA, Peterson YK, Zhu HJ, Appel DI, Peloquin CA, Markowitz JS. Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions. Pharmaceutical Research. 29: 972-82. PMID 22161308 DOI: 10.1007/s11095-011-0637-9 |
0.294 |
|
| 2011 |
Simon GR, Saddoughi S, Mukhopadhyay A, Peterson Y, Senkal CE, Oaks J, Perrotti D, Hannun Y, Ogretmen B. Targeting I2PP2A by FTY720: A novel, mechanism-based treatment strategy for patients with advanced and previously treated non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7574. PMID 28023125 DOI: 10.1200/Jco.2011.29.15_Suppl.7574 |
0.315 |
|
| 2010 |
Zhu HJ, Appel DI, Peterson YK, Wang Z, Markowitz JS. Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions. Toxicology. 270: 59-65. PMID 20097249 DOI: 10.1016/j.tox.2010.01.009 |
0.319 |
|
| 2009 |
Peterson YK, Wang XS, Casey PJ, Tropsha A. Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. Journal of Medicinal Chemistry. 52: 4210-20. PMID 19537691 DOI: 10.1021/Jm8013772 |
0.668 |
|
| 2008 |
Rao PV, Peterson YK, Inoue T, Casey PJ. Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Investigative Ophthalmology & Visual Science. 49: 2464-71. PMID 18316706 DOI: 10.1167/Iovs.07-1639 |
0.576 |
|
| 2007 |
Baron RA, Peterson YK, Otto JC, Rudolph J, Casey PJ. Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules. Biochemistry. 46: 554-60. PMID 17209565 DOI: 10.1021/Bi060344N |
0.549 |
|
| 2006 |
Roberts MJ, Troutman JM, Chehade KA, Cha HC, Kao JP, Huang X, Zhan CG, Peterson YK, Subramanian T, Kamalakkannan S, Andres DA, Spielmann HP. Hydrophilic anilinogeranyl diphosphate prenyl analogues are Ras function inhibitors. Biochemistry. 45: 15862-72. PMID 17176109 DOI: 10.1021/BI061704+ |
0.252 |
|
| 2006 |
Song KS, Peterson YK, Freidman A, Blumer JB, Sato M, Lanier SM. Identification and characterization of a G-protein regulatory motif in WAVE1. Febs Letters. 580: 1993-8. PMID 16530190 DOI: 10.1016/J.Febslet.2006.02.071 |
0.636 |
|
| 2006 |
Peterson YK, Kelly P, Weinbaum CA, Casey PJ. A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity. The Journal of Biological Chemistry. 281: 12445-50. PMID 16517596 DOI: 10.1074/Jbc.M600168200 |
0.587 |
|
| 2004 |
Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML, Lanier SM, Kalivas PW. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron. 42: 269-81. PMID 15091342 DOI: 10.1016/S0896-6273(04)00159-X |
0.61 |
|
| 2003 |
Bowers MS, Lake RW, McFarland K, Peterson YK, Lanier SM, Lapish CC, Kalivas PW. AGS3: a G-Protein regulator of addiction-associated behaviors. Annals of the New York Academy of Sciences. 1003: 356-7. PMID 14684460 DOI: 10.1196/Annals.1300.025 |
0.637 |
|
| 2003 |
Ghosh M, Peterson YK, Lanier SM, Smrcka AV. Receptor- and nucleotide exchange-independent mechanisms for promoting G protein subunit dissociation. The Journal of Biological Chemistry. 278: 34747-50. PMID 12881533 DOI: 10.1074/Jbc.C300271200 |
0.689 |
|
| 2003 |
Ma H, Peterson YK, Bernard ML, Lanier SM, Graber SG. Influence of cytosolic AGS3 on receptor--G protein coupling. Biochemistry. 42: 8085-93. PMID 12834360 DOI: 10.1021/Bi034561P |
0.68 |
|
| 2003 |
Gotta M, Dong Y, Peterson YK, Lanier SM, Ahringer J. Asymmetrically distributed C. elegans homologs of AGS3/PINS control spindle position in the early embryo. Current Biology : Cb. 13: 1029-37. PMID 12814548 DOI: 10.1016/S0960-9822(03)00371-3 |
0.62 |
|
| 2003 |
Blumer JB, Bernard ML, Peterson YK, Nezu J, Chung P, Dunican DJ, Knoblich JA, Lanier SM. Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alpha. The Journal of Biological Chemistry. 278: 23217-20. PMID 12719437 DOI: 10.1074/Jbc.C200686200 |
0.695 |
|
| 2002 |
Peterson YK, Hazard S, Graber SG, Lanier SM. Identification of structural features in the G-protein regulatory motif required for regulation of heterotrimeric G-proteins. The Journal of Biological Chemistry. 277: 6767-70. PMID 11756403 DOI: 10.1074/Jbc.C100699200 |
0.673 |
|
| 2001 |
Bernard ML, Peterson YK, Chung P, Jourdan J, Lanier SM. Selective interaction of AGS3 with G-proteins and the influence of AGS3 on the activation state of G-proteins Journal of Biological Chemistry. 276: 1585-1593. PMID 11042168 DOI: 10.1074/Jbc.M005291200 |
0.696 |
|
| 2000 |
Natochin M, Lester B, Peterson YK, Bernard ML, Lanier SM, Artemyev NO. AGS3 inhibits GDP dissociation from galpha subunits of the Gi family and rhodopsin-dependent activation of transducin. The Journal of Biological Chemistry. 275: 40981-5. PMID 11024022 DOI: 10.1074/Jbc.M006478200 |
0.675 |
|
| 2000 |
Peterson YK, Bernard ML, Ma H, Hazard S, Graber SG, Lanier SM. Stabilization of the GDP-bound conformation of Gialpha by a peptide derived from the G-protein regulatory motif of AGS3. The Journal of Biological Chemistry. 275: 33193-6. PMID 10969064 DOI: 10.1074/Jbc.C000509200 |
0.689 |
|
| Show low-probability matches. |